1.01

2.88% -0.03

Allarity Therapeutics Inc (ALLR)

Overview News Price History Financials Discussions Forecast Stock Split

Allarity Therapeutics Inc stock is traded at $1.01, with a volume of 365.89K. It is down -2.88% in the last 24 hours and down -2.88% over the past month. Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Previous Close:

$1.04

Open:

$1.01

24h Volume:

365.89K

Relative Volume:

0.66

Market Cap:

$15.23M

Revenue:

Net Income/Loss:

$-11.90M

P/E Ratio:

-0.0049

EPS:

-206.0125

Net Cash Flow:

$-12.75M

1W Performance:

-0.98%

1M Performance:

-2.88%

6M Performance:

-9.82%

1Y Performance:

+472.24%

1-Day Range:

$0.9804

$1.02

1-Week Range:

$0.9804

$1.17

52-Week Range:

$0.1131

$3.95

Allarity Therapeutics Inc Stock (ALLR) Company Profile

Name

Allarity Therapeutics Inc

Sector

Healthcare (1164)

Industry

Biotechnology (649)

Phone

401-426-4664

Address

24 SCHOOL ST., 2ND FLOOR, BOSTON

Employee

Twitter

Next Earnings Date

Latest SEC Filings

ALLR's Discussions on Twitter

Compare ALLR with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ALLR Allarity Therapeutics Inc	1.01	15.68M	0	-11.90M	-12.75M	-206.01
VRTX Vertex Pharmaceuticals Inc	462.13	117.32B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	558.87	58.89B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	401.80	51.14B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	673.80	41.02B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	299.01	32.59B	3.81B	-644.79M	-669.77M	-6.24

Allarity Therapeutics Inc Stock (ALLR) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-28-25	Initiated	Ascendiant Capital Markets	Buy

Allarity Therapeutics Inc Stock (ALLR) Latest News

04:59 AM

Analyzing Allarity Therapeutics Inc. with multi timeframe chartsLong-Term Safety Investment Analysis Report - Newser

04:59 AM

02:40 AM

What is the risk reward ratio of investing in Allarity Therapeutics Inc. stockBreakout Stocks Tracker With High Returns - jammulinksnews.com

02:40 AM

02:18 AM

How Allarity Therapeutics Inc. stock performs during market volatilityMulti-Year Signal Summary and Entry Timing - Newser

02:18 AM

12:18 PM

What makes Allarity Therapeutics Inc. stock price move sharplyLow Risk Watchlist With High Returns - jammulinksnews.com

12:18 PM

Aug 01, 2025

What is Allarity Therapeutics Inc. company’s growth strategyReal Time Insights For 2025 - jammulinksnews.com

Aug 01, 2025

What institutional investors are buying Allarity Therapeutics Inc. stockRetirement Planning Review With Proven Results - jammulinksnews.com

Aug 01, 2025

When is Allarity Therapeutics Inc. stock expected to show significant growthFree Stock Forecasts For 2025 - jammulinksnews.com

Aug 01, 2025

How to use Fibonacci retracement on Allarity Therapeutics Inc.Free Growth Based Investment Plan Guidance - Newser

Aug 01, 2025

Statistical indicators supporting Allarity Therapeutics Inc.’s strengthAI Stock Movement Forecast with Accuracy - Newser

Aug 01, 2025

Using RSI to spot recovery in Allarity Therapeutics Inc.Forecast Model for Intraday Buy Signals - Newser

Aug 01, 2025

Research Analysts Set Expectations for ALLR Q2 Earnings - Defense World

Aug 01, 2025

ALLR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Allarity Therapeutics, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Aug 01, 2025

Short interest data insights for Allarity Therapeutics Inc.Community Picked Stocks with Trade Insights - Newser

Aug 01, 2025

Will Allarity Therapeutics Inc. stock benefit from interest rate changesFree Buy Low Sell High Stock Watch - Newser

Aug 01, 2025

Jul 31, 2025

Is Allarity Therapeutics Inc. a candidate for recovery playFree Trend Analysis for Safer Trades - Newser

Jul 31, 2025

Published on: 2025-07-31 21:03:20 - Newser

Jul 31, 2025

Published on: 2025-08-01 02:43:27 - Newser

Jul 31, 2025

Why is Allarity Therapeutics Inc. stock attracting strong analyst attentionEarnings Report Insights To Watch Now - jammulinksnews.com

Jul 31, 2025

Jul 30, 2025

Why Allarity Therapeutics Inc. stock attracts strong analyst attentionDaily Trade Monitor with Pattern Alerts - Newser

Jul 30, 2025

Real time alert setup for Allarity Therapeutics Inc. performanceFree AI Driven Stock Trend Forecast - Newser

Jul 30, 2025

Support Zone Holds Steady for Allarity Therapeutics Inc. After DipEntry Alert Based on Volume Spikes Detected - metal.it

Jul 30, 2025

Jul 29, 2025

Is Allarity Therapeutics Inc. Forming a Bottom PatternTrade Setups With AI Powered Filters Published - beatles.ru

Jul 29, 2025

Will Allarity Therapeutics Inc. outperform the marketEarly Buy Opportunity with Chart Triggers - Newser

Jul 29, 2025

Published on: 2025-07-29 23:06:00 - metal.it

Jul 29, 2025